Todd Franklin Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), bought 60,988 shares at $6.38 ($109K) on 2023-05-31, disclosed to the SEC on 2023-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.38 | 1,463 | $9K | 8.5% |
| 2 | $1.68 | 59,525 | $100K | 91.5% |
| Total | $1.79 avg | 60,988 | $109K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |